-
Unlocking Value: Assessing the Cost-Effectiveness of Pitolisant Wakix®in Portugal
Sep 9, 2025, 16:22 PM -
Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico
Sep 9, 2025, 16:22 PM -
Balancing Power and Interpretation: Responder Analysis vs. Mean Differences for PRO Endpoints in Oncology Clinical Trials
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Generalized Pustular Psoriasis (GPP) in the Brazilian Private Healthcare System: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Pan-European Severity Assessment Methods and Their Uncertainty in Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Integration of Germany’s AMNOG Framework With the Joint Clinical Assessment Process
Sep 9, 2025, 16:22 PM -
A NICE Idea? Assessing the Impact of the Severity Modifier in Oncology and Nononcology Single Technology Appraisals
Sep 9, 2025, 16:22 PM -
Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?
Sep 9, 2025, 16:22 PM -
Underlying Systemic Motifs That Prevent Diabetes Patients From Seeking and Utilizing Health Services in a Country With a High Prevalence of Diabetes
Sep 9, 2025, 16:22 PM -
The Effect of Pharmaceutical Pricing Policies on Healthcare Expenditures in Turkey: Analysis for the Period 2015-2024
Sep 9, 2025, 16:22 PM -
HTA for Obesity and T2DM Indications: A Review and Recommendations for Future Appraisals
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Modeling the Environmental and Cost Impact of a Novel Detergent in NHS Endoscope Reprocessing Workflows
Sep 9, 2025, 16:22 PM -
Knowledge and Awareness of Primary Care Physicians (PCPs) Towards Respiratory Syncytial Virus (RSV) in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan
Sep 9, 2025, 16:22 PM -
A Strategic National Framework for Managed Entry Agreements to Access Innovative and Breakthrough Medications in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM -
Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Sep 9, 2025, 16:22 PM -
A Disease Progression Model Comparing Respiratory and Motor Decline in People With Late-Onset Pompe Disease Treated With Cipaglucosidase Alfa Plus Miglustat vs. Alglucosidase Alfa
Sep 9, 2025, 16:22 PM
